The Department of Health, Bureau of Health Services Financing will be holding a public hearing on Thursday, February 28 on proposed rules amending the Pharmacy Benefits Management Program changing the pharmacy ingredient cost reimbursement methodology from average acquisition cost (AAC) to the national average drug acquisition cost (NADAC).
Also in Louisiana…The Board of Pharmacy finalized regulations that took effect on January 20 modifying the prescription monitoring program regulations to include naloxone as a drug of concern, thus requiring reporting and tracking for public health purposes.
Also in Louisiana…The Board of Pharmacy announced the integration of the prescription monitoring program data into electronic health records (EHRs) and pharmacy management systems across the state. The goal is to minimize any workflow disruption by providing near-instant and seamless access to critical controlled substance prescription history information of patients to both prescribers and pharmacists directly within their EHRs and pharmacy management systems.
For more information, contact NACDS’ Mary Staples at 817-442-1155.